Medtronic Marks One Year of Transformation
The company's renewed focus on competitiveness and market share paid off in its fiscal year 2022, as Medtronic grew in the mid-single digits. May 31, 2022
SI-BONE Hits Procedure Volume Record in March
The company grew in the high single digits for 1Q22, driven by a company record for procedure volume in March. May 20, 2022
OrthoPediatrics’ Growing Surgeon Adoption Offsets Headwinds
The company grew in the high single digits for 1Q22 as its non-elective trauma business offset COVID-related elective procedure headwinds. May 19, 2022
Surgalign Looks to Extend Runway for HOLO Platform
The company declined in the double digits for 1Q22 as it continues the early commercialization efforts of its HOLO platform. May 19, 2022
Bioventus Focused on Double-Digit Growth and Debt Reduction
The company's orthopedic sales grew 9% organically in 1Q22 as Bioventus targets double-digit organic growth for the full year. May 17, 2022
Treace Benefits from Commercial Investments
The company grew more than 55% in 1Q22 on the strength of its narrow procedure focus and expanding direct sales force. May 17, 2022
Vericel Reaffirms MACI Guidance for 2022
The company grew in the high single-digits during a better than expected 1Q22 and restated its full-year guidance for MACI. May 16, 2022
Conformis Continues Business Model Transition
The company grew in the low-teens for 1Q22 as procedures rebounded, but its ongoing business model transition incurred higher costs. May 16, 2022
Globus Medical Continues Evolution Toward Full-Service Musculoskeletal Player
The company will embark on the next phase of its evolution under the guidance of new CEO Dan Scavilla, who has been with Globus since 2015. May 15, 2022
Paragon 28 Takes Share in Fast-Growing Segments
The company grew 25% in the first quarter of 2022 on the strength of its expanding portfolio, salesforce and surgeon base. May 13, 2022
